NAV

1,3-Propanediol

Identification

Generic Name
1,3-Propanediol
DrugBank Accession Number
DB02774
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 76.0944
Monoisotopic: 76.0524295
Chemical Formula
C3H8O2
Synonyms
  • 1,3-Dihydroxypropane
  • 1,3-propylene glycol
  • 2-(hydroxymethyl)ethanol
  • beta-Propylene glycol
  • Propane-1,3-diol
  • Trimethylene glycol
  • β-propylene glycol
External IDs
  • NSC-65426
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UHaloalkane dehalogenaseNot AvailablePseudomonas paucimobilis
UADP-ribosylation factor 1Not AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Coupling Chamomile Relax Premium massagelotionLotion2 g/100gTopicalACE PHARMACEUTICAL CO LTD2022-01-13Not applicableUS flag
Coupling Lavender Relax Premium massagelotionLotion2 g/100gTopicalACE PHARMACEUTICAL CO LTD2022-01-13Not applicableUS flag
Second 20 Y-ZONE SerumLiquid2 g/100gTopicalACE PHARMACEUTICAL CO LTD2022-01-13Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Coupling Chamomile Relax Premium massagelotion1,3-Propanediol (2 g/100g)LotionTopicalACE PHARMACEUTICAL CO LTD2022-01-13Not applicableUS flag
Coupling Lavender Relax Premium massagelotion1,3-Propanediol (2 g/100g)LotionTopicalACE PHARMACEUTICAL CO LTD2022-01-13Not applicableUS flag
Second 20 Y-ZONE Serum1,3-Propanediol (2 g/100g)LiquidTopicalACE PHARMACEUTICAL CO LTD2022-01-13Not applicableUS flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as primary alcohols. These are compounds comprising the primary alcohol functional group, with the general structure RCOH (R=alkyl, aryl).
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organooxygen compounds
Sub Class
Alcohols and polyols
Direct Parent
Primary alcohols
Alternative Parents
Hydrocarbon derivatives
Substituents
Aliphatic acyclic compound / Hydrocarbon derivative / Primary alcohol
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
propane-1,3-diols (CHEBI:16109) / a small molecule (CPD-347)
Affected organisms
Not Available

Chemical Identifiers

UNII
5965N8W85T
CAS number
504-63-2
InChI Key
YPFDHNVEDLHUCE-UHFFFAOYSA-N
InChI
InChI=1S/C3H8O2/c4-2-1-3-5/h4-5H,1-3H2
IUPAC Name
propane-1,3-diol
SMILES
OCCCO

References

Synthesis Reference

Dietrich Arntz, Norbert Wiegand, "Method for the production of 1,3-propandiol." U.S. Patent US5171898, issued May, 1991.

US5171898
General References
Not Available
KEGG Compound
C02457
PubChem Compound
10442
PubChem Substance
46508942
ChemSpider
13839553
RxNav
1363030
ChEBI
16109
ChEMBL
CHEMBL379652
ZINC
ZINC000001529437
PDBe Ligand
PDO
Wikipedia
1,3-Propanediol
PDB Entries
1d07 / 1iz8 / 1mr3 / 1nai / 1zv9 / 2o2i / 2ymt / 3fnk / 3l8q / 4bcx …
show 52 more

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
LotionTopical2 g/100g
LiquidTopical2 g/100g
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility859.0 mg/mLALOGPS
logP-1.2ALOGPS
logP-1.1Chemaxon
logS1.05ALOGPS
pKa (Strongest Acidic)15.6Chemaxon
pKa (Strongest Basic)-2.4Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area40.46 Å2Chemaxon
Rotatable Bond Count2Chemaxon
Refractivity19.42 m3·mol-1Chemaxon
Polarizability8.15 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9392
Blood Brain Barrier+0.8021
Caco-2 permeable-0.5053
P-glycoprotein substrateNon-substrate0.7765
P-glycoprotein inhibitor INon-inhibitor0.9345
P-glycoprotein inhibitor IINon-inhibitor0.9308
Renal organic cation transporterNon-inhibitor0.8877
CYP450 2C9 substrateNon-substrate0.8584
CYP450 2D6 substrateNon-substrate0.8753
CYP450 3A4 substrateNon-substrate0.8032
CYP450 1A2 substrateNon-inhibitor0.6856
CYP450 2C9 inhibitorNon-inhibitor0.9298
CYP450 2D6 inhibitorNon-inhibitor0.9553
CYP450 2C19 inhibitorNon-inhibitor0.9226
CYP450 3A4 inhibitorNon-inhibitor0.9505
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9385
Ames testNon AMES toxic0.7066
CarcinogenicityNon-carcinogens0.6187
BiodegradationReady biodegradable0.8591
Rat acute toxicity1.7183 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8656
hERG inhibition (predictor II)Non-inhibitor0.9458
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MS (2 TMS)GC-MSsplash10-00lr-2900000000-0e567dbe8fe1b032ef75
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-005a-9000000000-bad8799fb53a02fae87c
GC-MS Spectrum - EI-BGC-MSsplash10-057i-9000000000-8a78b7d323abef680fac
GC-MS Spectrum - EI-BGC-MSsplash10-057i-9000000000-32874f2605e2fa74ff9d
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-48caec9618268e1997c8
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-056r-9000000000-8141b03aa81a516b021a
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-f1d310daeae27abc7672
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4l-9000000000-099b21b48445cd2bf732
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-319b0aee1ce43cf5a94c
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-965e4f5c81b143dae8fa
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-105.3659753
predicted
DarkChem Lite v0.1.0
[M-H]-105.4255753
predicted
DarkChem Lite v0.1.0
[M-H]-105.5013753
predicted
DarkChem Lite v0.1.0
[M-H]-121.06746
predicted
DeepCCS 1.0 (2019)
[M+H]+106.9803753
predicted
DarkChem Lite v0.1.0
[M+H]+107.8002753
predicted
DarkChem Lite v0.1.0
[M+H]+106.4960753
predicted
DarkChem Lite v0.1.0
[M+H]+122.96287
predicted
DeepCCS 1.0 (2019)
[M+Na]+105.6626753
predicted
DarkChem Lite v0.1.0
[M+Na]+105.6343753
predicted
DarkChem Lite v0.1.0
[M+Na]+131.19142
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. Haloalkane dehalogenase
Kind
Protein
Organism
Pseudomonas paucimobilis
Pharmacological action
Unknown
General Function
Haloalkane dehalogenase activity
Specific Function
Catalyzes hydrolytic cleavage of carbon-halogen bonds in halogenated aliphatic compounds, leading to the formation of the corresponding primary alcohols, halide ions and protons. Has a broad substr...
Gene Name
linB
Uniprot ID
P51698
Uniprot Name
Haloalkane dehalogenase
Molecular Weight
33107.275 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
Details2. ADP-ribosylation factor 1
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Receptor signaling protein activity
Specific Function
GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking among different compartments. Modula...
Gene Name
ARF1
Uniprot ID
P84077
Uniprot Name
ADP-ribosylation factor 1
Molecular Weight
20696.62 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52